| Financial Year |
March 31 2023 |
| Monetary Funds |
1,701,096,720.60 |
| Held-for-trading Financial Assets |
470,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
492,961,302.86 |
| Advances to Suppliers |
6,328,635.04 |
| Other Receivables |
27,754,792.51 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
157,526,899.72 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,231,250.52 |
| Total Current Assets |
2,857,899,601.25 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
256,460.18 |
| Long-term Equity Investment |
3,528,358.43 |
| Investment Properties |
-- |
| Fixed Assetes |
1,784,179,961.74 |
| Under-construction Projects |
244,198,271.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
261,490,965.79 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,710,278.51 |
| Deferred Income Tax Assets |
64,126.10 |
| Other Non-Current Assets |
751,617.50 |
| Sub-Total of Non-Current Assets |
2,301,605,939.86 |
| Total Assets |
5,159,505,541.11 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
471,736,734.44 |
| Accounts Received In Advance |
17,848,386.02 |
| Employee Compensation Payable |
96,935,784.04 |
| Taxes Payable |
4,964,655.48 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
44,293,473.64 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
7,242,249.96 |
| Sub-Total of Current Liabilities |
832,525,997.98 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
763,268,396.23 |
| Total Liabilities |
1,595,794,394.21 |
| Paid-In Capital(Or Share Stock) |
444,444,445.00 |
| Capital Surplus |
1,178,257,445.27 |
| Surplus Reserve |
69,037,413.62 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,797,209,581.68 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,563,711,146.90 |
| Owner's Equity（Stockholder's Equity） |
3,563,711,146.90 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,159,505,541.11 |
